EchoGo Pro Receives FDA Clearance Is Now Available to Physicians in the U.S.: 1st of Kind Solution in Echocardiography

EchoGo Pro was trialed and validated in the UK and US, improving the diagnostic accuracy of clinicians for Coronary Artery Disease the most common form of heart disease and the leading cause of death in the U.S.

EchoGo Core at Mayo USA

Collaboration between Ultromics and Mayo Clinic aims to quantify cardiacinvolvement in COVID-19 and help triage high-risk patients with myocardial injury

Ultromics Develops World-first AI Technology Designed to Predict Heart Disease

The company reports breakthrough will save thousands of lives from the leading cause of death worldwide.